Unia Europejska -
rumuński -
EMA (European Medicines Agency)
zynrelef
heron therapeutics, b.v. - bupivacaine, meloxicam - durere, postoperator - anestezice - zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.
Mołdawia -
rumuński -
ANSA (Agenţia Naţională pentru Siguranţa Alimentelor)
globafix, pulbere, absorbant de micotoxine
global nutrition international, argentina - sodium - pulbere
Rumunia -
rumuński -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
thyrotop 38-7400 mbq
institute of isotopes co. ltd. - ungaria - natrii iodidum (131i) - caps. pt. uz terapeutic - 38-7400mbq - alte radiofarmaceutice de uz terapeutic compusi cu iod 131
Rumunia -
rumuński -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
moniyot-131 capsule t
monrol europe s.r.l. - ungaria - natrii iodidum (131i) - caps. pt. uz terapeutic - 37-7400mbq - alte radiofarmaceutice de uz terapeutic compusi cu iod 131
Rumunia -
rumuński -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
moniyot-131 capsule d
monrol europe s.r.l. - natrii iodidum (131i) - caps. - 0,37-36mbq - tiroida preparate pentru radiodiagnostic la nivelul tiroidei, varia
Rumunia -
rumuński -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
moniyot-131
monrol europe s.r.l. - ungaria - natrii iodidum (131i) - sol. orala pt. uz terapeutic - 14,8-3700mbq - alte radiofarmaceutice de uz terapeutic compusi cu iod 131
Rumunia -
rumuński -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
theracap 131 37mbq-5,550mbq
ge healthcare buchler gmbh & co. kg - germania - natrii iodidum (131i) - caps. - 37mbq-5,550mbq - alte radiofarmaceutice de uz terapeutic compusi cu iod 131
Unia Europejska -
rumuński -
EMA (European Medicines Agency)
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - agenți antineoplazici - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
Mołdawia -
rumuński -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
betadine 100 mg/ml soluţie cutanată
egis pharmaceuticals plc - povidoni iodidum - soluţie cutanată - 100 mg/ml
Mołdawia -
rumuński -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
betadine 100 mg/ml soluţie cutanată
egis pharmaceuticals plc - povidoni iodidum - soluţie cutanată - 100 mg/ml